ASP Isotopes Inc.ASPIEarnings & Financial Report
Nasdaq · Materials · Miscellaneous Chemical Products
ASP Isotopes Inc. is a specialty materials firm focused on developing and producing high-purity custom isotopes. Its products serve key sectors including nuclear medicine, targeted cancer therapies, advanced energy, and industrial research, with customers across North America, Europe and Asia Pacific.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| AK Jensen Investment Management Limited | 8.20% | 5.6M | ▼ -5.60pp | 2024-11-07 |
| Nos. of | 5.10% | 3.7M | — | 2024-11-14 |
Insider Transactions
Net 90d: +$418.4K · buys $881.5K / sells $463.1KRange:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-16-05:00 | Duncan Moore | Director | Sell (open market) | 11.6K | $5.21 | $60.6K |
| 2026-04-16-05:00 | Robert Ainscow | COO | Sell (open market) | 22.5K | $5.21 | $117.1K |
| 2026-04-15-05:00 | Heather Kiessling | Chief Financial Officer | Sell (open market) | 23.1K | $5.48 | $126.7K |
| 2026-03-06-05:00 | Robert Ainscow | COO | Sell (open market) | 25.0K | $4.51 | $112.8K |
| 2026-03-06-05:00 | Robert Ainscow | COO | Sell (open market) | 8.4K | $5.44 | $45.9K |
| 2026-03-02-05:00 | Mann Paul Elliot | Executive Chairman | Sell (open market) | 162.2K | $5.44 | $881.5K |
1–6 of 6